comparemela.com
  1. Home
  2. Live Updates
  3. Next Generation Capsids - Breaking News

Latest Breaking News On - Next generation capsids - Page 1 : comparemela.com

Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations

/PRNewswire/ Capsida Biotherapeutics ("Capsida") today announced new preclinical data supporting the potential of Capsida s gene therapy candidate, CAP-002,.

Mingshan xueCapsida biotherapeuticsWu chenSusan catalanoHuman genetics at baylor college of medicineDepartment of molecularCapsida program for genetic epilepsy dueBaltimore convention centerBaylor college of medicineDepartment of neuroscienceAmerican society of gene cell therapyCain foundation laboratoriesAssociate professorHuman geneticsBaylor collegeDan duncan neurological research institute

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.